TrialAdvances in therapy2016

Impact of Reduced Renal Function on the Glucose-Lowering Effects of Luseogliflozin, a Selective SGLT2 Inhibitor, Assessed by Continuous Glucose Monitoring in Japanese Patients with Type 2 Diabetes Mellitus.

Hideaki Jinnouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.